The mission of the California Institute for Regenerative Medicine (CIRM) is to accelerate world class science to deliver transformative regenerative medicine treatments in an equitable manner to a ...

The expected outcome of a CLIN2 award is completion of a single interventional clinical trial. CIRM anticipates funding between 9-16 CLIN2 awards in fiscal year 2025-2026, contingent on the number of ...

South San Francisco, CA, April 24, 2025 — The California Institute for Regenerative Medicine (CIRM), one of the world’s largest institutions dedicated to regenerative medicine, has approved awarding ...

Candidato terapéutico o dispositivo Plurocart consiste en condrocitos derivados de células madre pluripotentes, sembrados en un armazón; está destinado a tratar el cartílago dañado en la articulación ...

CIRM funds stem cell research to institutions throughout California. On the map below, click on any marker to learn more about our funding to that institution. You can explore the awards they’ve ...

Objetivo de la investigación El candidato terapéutico es una célula madre neuronal humana que secreta una proteína, ApiCCT1, que ayuda en la prevención de fenotipos de enfermedades, para su aplicación ...

Diabetes exacts a tremendous toll on patients, their families, and society in general. Autoimmune Type 1 diabetes, often called juvenile-onset diabetes, is caused by a person’s own immune system ...

Welcome to the frequently asked questions (FAQs) page of the California Institute for Regenerative Medicine (CIRM). Here, you’ll find answers to the most common questions you may have on CIRM. CIRM, ...

Objetivo de la investigación Describiremos, por primera vez, la dinámica de las células satélite musculares humanas, las miofibras y las células inmunes debido a ...

The California Institute for Regenerative Medicine (CIRM) was established in 2004 when 59 percent of California voters passed Proposition 71, also known as the California Stem Cell Research and Cures ...

两所世界知名的研究型大学及其区域合作伙伴将联手创建 CIRM Alpha 干细胞诊所 (ASCC) 联盟。凭借我们各自的机构知识和集体经验，我们拥有独特的资格，可以建立提供干细胞疗法和教育的最佳 ...